SCHEMBL31420239

SCHEMBL31420239

CCc1ncccc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062239 1.00
SCHEMBL3066461 0.83 PDE3B (0.38)
SCHEMBL10268371 0.79 L3MBTL1 (0.42)
SCHEMBL507581 0.79
SCHEMBL30201085 0.79
SCHEMBL4625922 0.78 TDP1 (0.49)
SCHEMBL10041246 0.77
SCHEMBL3087900 0.77
SCHEMBL19743753 0.77
Bromide SCHEMBL11700455 0.77 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257076-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2025-08-14 US disclosed
CN-119350519-B Inonotus obliquus polysaccharide IOP-1 with non-small cell lung cancer resisting activity and application thereof 长春中医药大学 2025-04-29 CN disclosed
CN-119350519-A Inonotus obliquus polysaccharide IOP-1 with non-small cell lung cancer resisting activity and application thereof 长春中医药大学 2025-01-24 CN disclosed